Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Goodwill & Intangibles of $1.2 billion for Q2 2026, down 4.66% on a QoQ basis from $1.3 billion in Q1 2026, and down 2.13% year-over-year from $1.3 billion in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Goodwill & Intangibles for 18 years, with the latest figure at $1.2 billion in Q2 2026.
- On a quarterly basis, Goodwill & Intangibles fell 2.13% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 2.13% decrease from a year earlier, with the FY2026 full-year figure at $1.3 billion, up 5.06% from the prior year.
- Goodwill & Intangibles was $1.2 billion for Q2 2026 at Dr Reddys Laboratories, down from $1.3 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $1.3 billion in Q3 2025, with the low at $421.1 million in Q1 2022.
- Average Goodwill & Intangibles over 5 years is $822.3 million, with a median of $507.1 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles declined 23.65% in 2022, then soared 153.43% in 2025.
- Over 5 years, Goodwill & Intangibles stood at $431.2 million in 2022, then climbed by 14.73% to $494.7 million in 2023, then jumped by 150.85% to $1.2 billion in 2024, then climbed by 3.81% to $1.3 billion in 2025, then slipped by 4.51% to $1.2 billion in 2026.
- The last three Goodwill & Intangibles figures came in at $1.2 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.29 Bn |
| Sep 30, 2025 | 1.30 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.24 Bn |
| Sep 30, 2024 | 1.24 Bn |
| Jun 30, 2024 | 495.98 Mn |
| Mar 31, 2024 | 496.16 Mn |
| Dec 31, 2023 | 494.71 Mn |
| Sep 30, 2023 | 499.34 Mn |
| Jun 30, 2023 | 514.93 Mn |
| Mar 31, 2023 | 426.91 Mn |
| Dec 31, 2022 | 431.18 Mn |
| Sep 30, 2022 | 452.59 Mn |
| Jun 30, 2022 | 469.63 Mn |
| Mar 31, 2022 | 421.10 Mn |
| Dec 31, 2021 | 488.23 Mn |
| Sep 30, 2021 | 502.14 Mn |